The softer side of bleeding

Journal of the American College of Cardiology

Volumn 61, Issue 21, 2013, Pages 2139-2141

  Dauerman, Harold L ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

antiplatelet therapy; bleeding; percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; EVEROLIMUS; PRASUGREL; STREPTOKINASE; TICAGRELOR; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; BLEEDING; CORONARY STENT; DEPRESSION; DRUG ELUTING STENT; HEART ATRIUM FIBRILLATION; HUMAN; NOTE; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL MOBILITY; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 84877994235     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.03.013     Document Type: Editorial

References (19)

1. H.L. Dauerman, S.V. Rao, F.S. Resnic, R.J. Applegate Bleeding avoidance strategies. Consensus and controversy J Am Coll Cardiol 58 2011 1 10
2. P.G. Steg, K. Huber, F. Andreotti Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology Eur Heart J 32 2011 1854 1864
3. G.N. Levine, E.R. Bates, J.C. Blankenship 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44 e122
4. R. Mehran, S.V. Rao, D.L. Bhatt Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
5. B. Ahmed, W.D. Piper, D. Malenka Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry Circ Cardiovasc Interv 2 2009 423 429
6. A.P. Amin, A. Bachuwar, K.J. Reid Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health status J Am Coll Cardiol 61 2013 2130 2138
7. M.T. Roe, P.W. Armstrong, K.A. Fox Prasugrel versus clopidogrel for acute coronary syndromes without revascularization N Engl J Med 367 2012 1297 1309
8. L. Mauri, D.J. Kereiakes, S.L. Normand Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions Am Heart J 160 2010 1035 1041
9. S.D. Wiviott, E. Braunwald, C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
10. S.S. Jolly, S. Yusuf, J. Cairns Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial Lancet 377 2011 1409 1420
11. P. Roy, L. Bonello, R. Torguson Impact of "nuisance" bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluting stent implantation Am J Cardiol 102 2008 1614 1617
12. I. Ben-Dor, R. Torguson, M. Scheinowitz Incidence, correlates, and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug-eluting stents Am Heart J 159 2010 871 875
13. T.Y. Wang, L. Xiao, K.P. Alexander Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding Circulation 118 2008 2139 2145
14. R.C. Becker, J.P. Bassand, A. Budaj Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial Eur Heart J 32 2011 2933 2944
15. D.L. Bhatt, K.A. Fox, W. Hacke Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events N Engl J Med 354 2006 1706 1717
16. P.B. Berger, D.L. Bhatt, V. Fuster Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial Circulation 121 2010 2575 2583
17. P. Meier, A.J. Lansky Optimal duration of clopidogrel therapy: the shorter the longer? Eur Heart J 2012 Nov 7 [E-pub ahead of print]
18. G.W. Stone, A. Rizvi, K. Sudhir Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial J Am Coll Cardiol 58 2011 19 25
19. B. Ahmed, H.L. Dauerman Women, bleeding, and coronary intervention Circulation 127 2013 641 649